首页> 外文期刊>Stroke: A Journal of Cerebral Circulation >Treatment of intraventricular hemorrhage with urokinase : effects on 30-Day survival.
【24h】

Treatment of intraventricular hemorrhage with urokinase : effects on 30-Day survival.

机译:尿激酶治疗脑室内出血:对30天生存期的影响。

获取原文
获取原文并翻译 | 示例
           

摘要

BACKGROUND AND PURPOSE: Intraventricular hemorrhage (IVH) remains associated with high morbidity and mortality. Therapy with external ventricular drainage alone has not modified outcome in these patients. METHODS: Twelve pilot IVH patients who required external ventricular drainage were prospectively treated with intraventricular urokinase followed by the randomized, double-blinded allocation of 8 patients to either treatment or placebo. Observed 30-day mortality was compared with predicted 30-day mortality obtained by use of a previously validated method. RESULTS: Twenty patients were enrolled; admission Glasgow Coma Scale score in 11 patients was
机译:背景与目的:脑室内出血(IVH)仍然与高发病率和高死亡率相关。这些患者单用外部心室引流治疗并没有改变预后。方法:十二名需要外部室引流的IVH飞行员接受了脑室内尿激酶的前瞻性治疗,随后随机,双盲分配8名患者接受治疗或安慰剂治疗。将观察到的30天死亡率与通过使用先前验证的方法获得的预计30天死亡率进行比较。结果:招募了20例患者。 11例患者的格拉斯哥昏迷量表评分为

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号